2008
DOI: 10.1128/jvi.02442-07
|View full text |Cite
|
Sign up to set email alerts
|

Anticapsid Immunity Level, Not Viral Persistence Level, Correlates with the Progression of Theiler's Virus-Induced Demyelinating Disease in Viral P1-Transgenic Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
29
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 24 publications
(34 citation statements)
references
References 59 publications
5
29
0
Order By: Relevance
“…Therefore, epitope-specific cytotoxic CD8 ϩ T cells may similarly play a protective or pathogenic role depending on the type and/or reactivity of epitopes. We previously demonstrated that the level of the VP3 159-166 -specific CD8 ϩ T cell response in susceptible SJL mice is inversely correlated with viral persistence in P1-transgenic (P1-Tg) SJL mice (40), highlighting the importance of VP3 159-166 -specific CD8 ϩ T cells in limiting the viral load in vivo. Surprisingly, however, higher viral persistence in P1-Tg mice did not lead to a higher disease incidence and/or severity.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, epitope-specific cytotoxic CD8 ϩ T cells may similarly play a protective or pathogenic role depending on the type and/or reactivity of epitopes. We previously demonstrated that the level of the VP3 159-166 -specific CD8 ϩ T cell response in susceptible SJL mice is inversely correlated with viral persistence in P1-transgenic (P1-Tg) SJL mice (40), highlighting the importance of VP3 159-166 -specific CD8 ϩ T cells in limiting the viral load in vivo. Surprisingly, however, higher viral persistence in P1-Tg mice did not lead to a higher disease incidence and/or severity.…”
Section: Discussionmentioning
confidence: 99%
“…ϩ T cell responses to subdominant epitopes (40). Interestingly, P1-transgenic SJL mice lacking CD8 ϩ T cell responses to the predominant epitope develop less severe delayed clinical disease.…”
Section: T Has Been Well Established That Virus-specific Cd8mentioning
confidence: 99%
“…This shows that administration of anti-PD-1 mAb did not affect the viral load in the CNS, despite the deteriorated disease development. There are increasing evidences that viral persistence levels are not associated with the development of TMEV-IDD (Myoung et al, 2008;Jin et al, 2009). Viral persistence alone may not be sufficient to induce the disease and that the level of T cell immunity to viral capsid epitopes may be critical for the development of demyelinating disease in SJL mice (Myoung, Bahk, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, clonal expansion of certain CD8 ϩ T cells may be associated with the pathogenesis of demyelinating diseases. However, B6 mice, which are resistant to TMEV-induced demyelinating disease, induce strong CD8 ϩ T-cell responses to a single predominant epitope (VP2 121-130 ), i.e., Ն70% of CNSinfiltrating CD8 ϩ T cells (41,42). These CD8 ϩ T cells result in effective viral clearance yet remain at a low level in the CNS more than 120 days postinfection (dpi) without detectable pathology (42).…”
mentioning
confidence: 99%
“…However, B6 mice, which are resistant to TMEV-induced demyelinating disease, induce strong CD8 ϩ T-cell responses to a single predominant epitope (VP2 121-130 ), i.e., Ն70% of CNSinfiltrating CD8 ϩ T cells (41,42). These CD8 ϩ T cells result in effective viral clearance yet remain at a low level in the CNS more than 120 days postinfection (dpi) without detectable pathology (42). This inconsistency led us to investigate the shape and quality of the T-cell receptor (TCR) repertoire accumulating in the CNSs of B6 mice.…”
mentioning
confidence: 99%